Ilan Hadar insider trades

Open-market stock purchases and sales by Ilan Hadar, Chairman and CEO at Silexion Therapeutics Corp, from SEC Form 4 filings since Jan 1, 2018.

Recent trades

DateStockTradeValue
Jun 4, 2026SLXN Silexion Therapeutics CorpBought (not open market)—
Feb 20, 2026SLXN Silexion Therapeutics CorpBought (not open market)—

Companies traded

  • SLXN Silexion Therapeutics Corp: other filings, last Jun 4, 2026
  • FOMX Foamix Pharmaceuticals Ltd: 2 sales, last Mar 9, 2020
  • MNLO Menlo Therapeutics Inc: other filings, last Mar 9, 2020

Get free alerts when Ilan Hadar files a new trade →